The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-chloro-N3-(1,3-dimethyl-2-oxo-1,2-dihydroquinolin-6-yl)-N1-hydroxyisophthalamide ID: ALA4790363
PubChem CID: 162668960
Max Phase: Preclinical
Molecular Formula: C19H16ClN3O4
Molecular Weight: 385.81
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2cc(NC(=O)c3cc(C(=O)NO)ccc3Cl)ccc2n(C)c1=O
Standard InChI: InChI=1S/C19H16ClN3O4/c1-10-7-12-8-13(4-6-16(12)23(2)19(10)26)21-18(25)14-9-11(17(24)22-27)3-5-15(14)20/h3-9,27H,1-2H3,(H,21,25)(H,22,24)
Standard InChI Key: QNBKPOQRRXZDRO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
24.3781 -21.1396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3770 -21.9592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0850 -22.3681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7947 -21.9587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7919 -21.1360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0832 -20.7308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4996 -20.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2088 -21.1304 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.4965 -19.9073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6703 -20.7312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6701 -19.9140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9627 -21.1400 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9623 -19.5056 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.2026 -19.4961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9086 -19.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6143 -19.4928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1947 -18.6819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8975 -18.2690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6077 -18.6747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3102 -18.2647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3087 -17.4474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5985 -17.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8898 -17.4534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5955 -16.2246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0151 -17.0365 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.0193 -18.6710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5030 -22.3662 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
7 9 1 0
5 7 1 0
1 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
9 14 1 0
14 15 2 0
15 16 1 0
16 19 2 0
18 17 2 0
17 14 1 0
18 19 1 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
22 24 1 0
21 25 2 0
20 26 1 0
4 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 385.81Molecular Weight (Monoisotopic): 385.0829AlogP: 2.87#Rotatable Bonds: 3Polar Surface Area: 100.43Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.01CX Basic pKa: ┄CX LogP: 2.40CX LogD: 2.39Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.48Np Likeness Score: -1.30
References 1. Ghazy E,Zeyen P,Herp D,Hügle M,Schmidtkunz K,Erdmann F,Robaa D,Schmidt M,Morales ER,Romier C,Günther S,Jung M,Sippl W. (2020) Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1., 200 [PMID:32497960 ] [10.1016/j.ejmech.2020.112338 ]